Astra Pulmicort Turbuhaler First Quarter U.S. Sales Reach $16.9 Mil.
Executive Summary
U.S. sales for Astra's Pulmicort Turbuhaler reached about $16.9 mil. (SEK 133 mil.) in the first quarter following the completion of a "gradual market introduction" of the corticosteroid dry powder inhaler in the U.S., the company said April 27.